about
Misfolded CuZnSOD and amyotrophic lateral sclerosisALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomesReactive oxygen species in health and diseaseAlsin is a Rab5 and Rac1 guanine nucleotide exchange factorA mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration.Amyotrophic lateral sclerosis: an emerging era of collaborative gene discoveryRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Complex genetics of amyotrophic lateral sclerosis.Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agentsRole of oxidative stress and antioxidants in neurodegenerative diseases.Targeting cellular energy production in neurological disorders.Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.Flightless flies: Drosophila models of neuromuscular disease.Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects.Progression in primary lateral sclerosis: a prospective analysis.Amino acid transporters: roles in amino acid sensing and signalling in animal cells.Familial motor neurone disease with dementia: phenotypic variation and cerebellar pathology.Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease.Influence of diagnostic categories, age, and gender on antioxidative defense and lipid peroxidation in skeletal muscle of patients with neuromuscular diseases.Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants.Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studiesAmyotrophic lateral sclerosis: a hormonal condition?The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.Strategy for treating motor neuron diseases using a fusion protein of botulinum toxin binding domain and streptavidin for viral vector access: work in progress.Genotype-phenotype relationships in familial amyotrophic lateral sclerosis with FUS/TLS mutations in Japan.Effect of Oxidative Damage on the Stability and Dimerization of Superoxide Dismutase 1.Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration.Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice.Mitochondriopathy as a differential diagnosis of amyotrophic lateral sclerosis.Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice.Age dependent penetrance of three different superoxide dismutase 1 (sod 1) mutations.Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis.Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis
P2860
Q24683677-EB5A1A2A-94C8-4434-B5B0-8358369E3721Q24792140-AAFD4C1D-6BDC-482A-A6CC-7AFC8E28D882Q26851203-3AA2AC44-8DDE-4B49-BDDE-91AB664DDAE8Q28509300-2789A371-3A3A-4852-8A49-C8E1C3CBD9F2Q28585283-D0E5C796-C1D6-41CF-A00D-490EE3FB8C40Q30444138-EE64B4A0-CCA3-4CDB-A42F-9E6FE4C9B99FQ30446460-63028614-0AD8-4782-98FD-4640DEDE427AQ33910597-3F617368-C227-4982-BADE-6A8689646121Q34051858-253A1E14-99B9-4CEA-9000-3A6A3F8A78AFQ34154938-ADD9944F-1167-4624-9734-0CBA83608DA9Q34266266-F958126B-46BF-468A-B087-3DA741BEA6F4Q34311332-B1A485CE-6D12-4C88-B6BA-76E4925F553DQ34708090-CE259814-C9A6-4C22-AD10-DBF160A3E6B8Q34981294-04D857A4-A1DC-4F3C-8873-F2E5EC76FA41Q35013428-36B6C36E-6018-443B-8211-DB07F120E252Q35184476-BEAE1531-DCA9-415F-B335-A6808A47FC0EQ35470942-2BEA0325-4E3D-42F6-BD4D-731C1B62CB71Q35741414-C2D26A40-840E-4A66-9706-6A0A5EA0BB3AQ36275094-B372C662-6D19-4473-8967-32D00C928E11Q37646220-F4153E88-3D0B-4B4C-997E-AC24783F9E31Q37713198-A5D3C8D6-707C-4059-98B0-8C50EEC690F9Q37960537-232E53D1-07F6-4A6A-A29E-28D77A4981BBQ38032904-C56E1764-8B46-4883-B158-84E371E9EF55Q38233270-7C2F45EF-2534-4019-956C-A4E3D1642407Q39446005-832DD163-432E-44F9-82B9-57840BA30275Q40045594-8F06EE97-B66C-43B6-8001-EBFB5E73AA63Q40248187-3488FC3D-23EB-4501-BAE6-FA096B9E8144Q40323686-325B33BB-1E29-460D-93F1-F20B533BA7B1Q43261428-40CAB97C-D265-4A13-8C3A-5D656C08378BQ44413482-56E5AFED-2891-47DC-8024-B842C4B6FAA8Q45223589-7FFA42A9-651F-41DE-89A9-1609A15E406CQ47301610-D963AF22-4DF0-405E-8EDC-BAF5514A6485Q48450897-15271E2D-A552-405F-9104-95A3D715FC8FQ48881997-221D1D39-589A-4FBC-8A0C-4F95C7766647Q58125423-C6372A37-27EB-40A9-998F-CCF77BE40DB5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Familial amyotrophic lateral sclerosis.
@ast
Familial amyotrophic lateral sclerosis.
@en
Familial amyotrophic lateral sclerosis.
@nl
type
label
Familial amyotrophic lateral sclerosis.
@ast
Familial amyotrophic lateral sclerosis.
@en
Familial amyotrophic lateral sclerosis.
@nl
prefLabel
Familial amyotrophic lateral sclerosis.
@ast
Familial amyotrophic lateral sclerosis.
@en
Familial amyotrophic lateral sclerosis.
@nl
P2860
P356
P1433
P1476
Familial amyotrophic lateral sclerosis.
@en
P2860
P304
P356
10.1002/MUS.10001
P577
2002-02-01T00:00:00Z